{"result": "\n{\n    \"title\": \"APROCCHSS Trial and Sepsis Treatment\",\n    \"summary\": \"The community centers around the APROCCHSS trial, a significant clinical study evaluating treatments for septic shock. Key entities include the trial itself, the drugs involved, and the funding bodies. The trial's outcomes have implications for the treatment of septic shock, particularly with the use of hydrocortisone and fludrocortisone, and are influenced by the withdrawal of Xigris from the market.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the trial's significant implications for septic shock treatment and its influence on clinical practices.\",\n    \"findings\": [\n        {\n            \"summary\": \"APROCCHSS trial's focus on septic shock treatment\",\n            \"explanation\": \"The APROCCHSS trial is a pivotal study designed to evaluate the effects of hydrocortisone-plus-fludrocortisone therapy and drotrecogin alfa (activated) on septic shock. This trial demonstrated a survival benefit in adults with septic shock and persistent vasopressor dependency when treated with hydrocortisone plus fludrocortisone [Data: Entities (636); Relationships (174, 205, 210, 1026, 1031)].\"\n        },\n        {\n            \"summary\": \"Impact of Xigris withdrawal on the APROCCHSS trial\",\n            \"explanation\": \"Xigris, a drug used in the treatment of severe sepsis, was withdrawn from the market in October 2011, which affected the continuation of the APROCCHSS trial. This withdrawal had significant implications for the trial's design and outcomes, as drotrecogin alfa (activated), also known by its brand name Xigris, was initially used in the trial [Data: Entities (643, 635); Relationships (177, 173, 1034, 1027)].\"\n        },\n        {\n            \"summary\": \"Funding and support for the APROCCHSS trial\",\n            \"explanation\": \"The APROCCHSS trial was funded by the Programme Hospitalier de Recherche Clinique 2007 and the French Ministry of Social Affairs and Health. This support was crucial for the trial's execution and highlights the importance of governmental backing in clinical research [Data: Entities (637, 638); Relationships (1028, 1029)].\"\n        },\n        {\n            \"summary\": \"Registration and recognition of the APROCCHSS trial\",\n            \"explanation\": \"The APROCCHSS trial is registered under the ClinicalTrials.gov identifier NCT00625209, ensuring its recognition and accessibility in the clinical research community. This registration is a testament to the trial's significance and adherence to research standards [Data: Entities (639); Relationships (1030)].\"\n        },\n        {\n            \"summary\": \"Comparison with other clinical trials\",\n            \"explanation\": \"The APROCCHSS trial's findings are comparable to those of the GER-INF-05 trial, both showing a survival benefit with hydrocortisone plus fludrocortisone in septic shock patients. Additionally, the trial's mortality rates were close to those reported by the Sepsis-3 task force, further validating its results [Data: Entities (657, 659); Relationships (1031, 1032)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n636,APROCCHSS,The Activated Protein C and Corticosteroids for Human Septic Shock (APROCCHSS) trial is a clinical study designed to evaluate the effects of hydrocortisone-plus-fludrocortisone therapy and drotrecogin alfa (activated) on septic shock. This trial demonstrated a survival benefit in adults with septic shock and persistent vasopressor dependency when treated with hydrocortisone plus fludrocortisone.,10\n643,XIGRIS,\"Xigris was a drug used in the treatment of severe sepsis. It was withdrawn from the market in October 2011, which affected the continuation of the APROCCHSS trial.\",4\n635,DROTRECOGIN ALFA (ACTIVATED),\"Drotrecogin alfa (activated) is a human recombinant activated protein C that was initially used to treat sepsis. It was involved as a trial agent compared against a placebo in a study. However, it was withdrawn from the market in 2011.\",3\n637,PROGRAMME HOSPITALIER DE RECHERCHE CLINIQUE 2007,A funding program by the French Ministry of Social Affairs and Health that supported the APROCCHSS trial,1\n638,FRENCH MINISTRY OF SOCIAL AFFAIRS AND HEALTH,The governmental body responsible for funding the APROCCHSS trial,1\n639,NCT00625209,The ClinicalTrials.gov identifier for the APROCCHSS trial,1\n657,GER-INF-05,\"A clinical trial where patients received hydrocortisone plus fludrocortisone or matching placebos for 7 days, showing a survival benefit in septic shock patients\",1\n659,SEPSIS-3,A task force that reported crude in-hospital mortality rates for septic shock patients,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n174,SEPTIC SHOCK,APROCCHSS,The APROCCHSS trial was conducted to evaluate treatments for septic shock,80\n177,SEPTIC SHOCK,XIGRIS,Xigris was previously used in the treatment of septic shock before its withdrawal from the market,74\n173,SEPTIC SHOCK,DROTRECOGIN ALFA (ACTIVATED),Drotrecogin alfa (activated) was initially used to treat septic shock but was later withdrawn,73\n205,HYDROCORTISONE,APROCCHSS,The APROCCHSS trial tested the efficacy of hydrocortisone in treating septic shock,31\n471,SURVIVING SEPSIS CAMPAIGN,APROCCHSS,The APROCCHSS trial focused on patients whose condition did not improve after initial resuscitation according to the Surviving Sepsis Campaign guidelines,19\n210,FLUDROCORTISONE,APROCCHSS,The APROCCHSS trial tested the efficacy of fludrocortisone in treating septic shock,17\n1026,DROTRECOGIN ALFA (ACTIVATED),APROCCHSS,The APROCCHSS trial tested the efficacy of drotrecogin alfa (activated) in treating septic shock,13\n1028,APROCCHSS,PROGRAMME HOSPITALIER DE RECHERCHE CLINIQUE 2007,The APROCCHSS trial was funded by the Programme Hospitalier de Recherche Clinique 2007,11\n1029,APROCCHSS,FRENCH MINISTRY OF SOCIAL AFFAIRS AND HEALTH,The French Ministry of Social Affairs and Health funded the APROCCHSS trial,11\n1030,APROCCHSS,NCT00625209,The APROCCHSS trial is registered under the ClinicalTrials.gov identifier NCT00625209,11\n1031,APROCCHSS,GER-INF-05,Both trials showed a survival benefit with hydrocortisone plus fludrocortisone in septic shock patients,11\n1032,APROCCHSS,SEPSIS-3,The APROCCHSS trial's mortality rates were close to those reported by the Sepsis-3 task force,11\n1034,APROCCHSS TRIAL,XIGRIS,The withdrawal of Xigris from the market affected the continuation of the APROCCHSS trial,8\n1027,DROTRECOGIN ALFA (ACTIVATED),XIGRIS,\"Drotrecogin alfa (activated), also known by its brand name Xigris, was involved in the treatment of severe sepsis. However, it was eventually withdrawn from the market.\",7\n1036,XIGRIS,CORTICUS,The potential interaction between drotrecogin alfa (Xigris) and corticosteroids was not assessed in the CORTICUS trial,6\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}